Skip to main content
Gastroenterology and Hepatology From Bed to Bench logoLink to Gastroenterology and Hepatology From Bed to Bench
. 2020 Winter;13(Suppl1):S128–S133.

Detection and characterization of rotavirus G and P types from children with acute gastroenteritis in Qom, central Iran

Saeed Shams 1, Seyed Dawood Mousavi Nasab 2,3, Hosein Heydari 4, Javad Tafaroji 4, Nayebali Ahmadi 5, Esmaeil Shams Afzali 6
PMCID: PMC7881410  PMID: 33585014

Abstract

Aim:

The aim of the study is to estimate the burden of Rotavirus gastroenteritis as well as predominant genotypes of Rotavirus among children less than 5 years of age referring to Pediatric University Hospital in Qom, Iran.

Background:

Gastroenteritis is the fourth most common cause of death and accounts for 16% of all deaths in children <5 years of age worldwide.

Methods:

During two years, 130 patients referring to a pediatric hospital were enrolled in this study. After RNA extraction, Rotaviruses were detected by the VP6 gene. Then, G-typing (G1, G2, G3, G4, G8, G9, and G12) and P-typing (P4, P6, and P8) were performed using RT-PCR and specific primers.

Results:

The results of the PCR revealed that from a total of 130 patients, 22 cases (16.9%) showed positive VP6 by RT-PCR. G1 was mostly the predominant serotype (27%), accounting for 22% of all VP7-positive isolates, followed by G9 (18%), G2 (9%), G3 (9%), and G4 (9%). None of the strains revealed the presence of G8 genotype (0%), and 5 specimens (23%) were non-typable. The frequency of P typing was P8 (50%), P6 (23%), P4 (14%), and 3 samples were P-non-typable (13%), respectively. The dominant G-P combination was G1 [8] (32%).

Conclusion:

Such studies based on typing methods assists in the Rotavirus vaccine introduction by policymakers and design of new effective vaccines.

Key Words: Diarrhea, Rotavirus, Genotyping, acute gastroenteritis, vaccine, Iran

Introduction

Studies have generally shown that among infectious diseases, gastroenteritis is the fourth most common cause of death and accounts for 16% of all deaths in children <5 years of age worldwide (1, 2). It is estimated that only 20% of gastroenteritis is caused by bacterial agents, while the rest is caused by viruses. In epidemiological studies, diarrhea is usually defined as the passage of three or more loose or watery stools within 24 hours (3). The most significant viral agents as leading cause of acute gastroenteritis are Rotavirus, Calicivirus, Adenovirus, and Astrovirus. Rotavirus (RV) is known as the major agent of severe diarrhea among infants and young children with a high prevalence of morbidity and mortality worldwide (4, 5). The main clinical symptoms include watery diarrhea along with vomiting and fever which can result in dehydration, electrolyte imbalance, and death in young children below the age of 5 (6, 7). Rotaviruses belong to the family Reoviridae and based on RNA divergent sequence in VP6 region, they can be divided into eight groups named A–H (8). Species A rotavirus, which is a major cause of serious childhood dehydration gastroenteritis and has been reported to cause approximately a million deaths annually, mostly occurs in developing countries (3). These are non-enveloped agents with triple-layered capsid protein that surrounds a double-stranded RNA with eleven gene segments. The outer shell contains Rotaviruses composed of two proteins (elicit neutralizing antibody), the glycoprotein VP7 (G protein) and VP4 (P protein), which can further be differentiated into 23 G-type and 32 P-type, respectively (9, 10). Rotavirus strain entities may differ over time due to point mutations, genetic animal-human reassortment.

Molecular techniques such as Reverse Transcription- PCR (RT-PCR) has enhanced our understanding of the diversity of Rotavirus strains (11). No specific treatment of RV infection is available and only supportive care for dehydration and its complications are recommended. It seems that vaccination is the most effective prevention strategy (12). It is estimated that expanded vaccination of the Rotavirus could prevent ~27 000 deaths in 2016 (13, 14). G1P8, G2P4, G3P8, G4P8, and G9P8 are the most common Rotavirus genotypes reported around the world (15). Thus, an increased understanding of the distribution of G and P genotypes strains circulating in different regions of the country is crucial before introducing rotavirus vaccines (16, 17). No study on the genotyping data has been reported in Qom city of Iran. So, the present work aimed to estimate the burden of Rotavirus gastroenteritis as well as predominant genotypes of Rotavirus among children less than five years of age referring to pediatric University Hospital in Qom, Iran.

Methods

Patients and sample collection

The study was approved by the Medical Ethics Committee of Qom University of Medical Sciences (IR.MUQ.REC.1394.129). After written informed consent was obtained from each participant or their parents, the patients joined the project. A total of 130 patients exhibiting symptoms of diarrhea admitted to Pediatric Hospital Medical Center, Qom, Iran (2017-2019) were enrolled in this study. They were suspected to have a viral infection and their stool exams were negative for RBC and WBC. Further, all tests for other enteric bacteria and parasites were negative. For Rotavirus characterization, the specimens were sent to the Cellular and Molecular Research Center of the university, and were stored at -80°C until use. The questionnaire was used for collecting all clinical, laboratory, and demographic characteristics.

RNA extraction and cDNA Synthesis

Fecal samples were prepared as a 10% (wt/vol) suspension of feces in 0.01 M phosphate-buffered saline (PBS; pH 7) and all samples were centrifuged at 5000×g for 5 min at 4°C, with the supernatants tested and then stored in sterile vials at −80°C for further study for RNA extraction. The supernatant was discarded and the viral dsRNA was extracted formed pellet by using CinnaPure Viral kit according to the manufacturer's protocol (SinaClon, Iran). cDNA synthesis was also accomplished using Biofact™ RT Series kit according to the manufacturer's instructions (Biofact, South Korea). The synthetized cDNAs were stored at -20°Cuntil analyzed by PCR.

Table 2.

Comparison of age, gender, and season between both Rotavirus-negative and Rotavirus-positive patients

Variable All patients (n=130) Rotavirus-positive patients (n=23) Rotavirus-negative patients (n=107) p-value
Age, Mean±SD (Month) 32.09±32.68 32.82±34.76 31.93±32.38 0.906
Gender Male, N (%) 78 (60) 16 (69.6) 62 (57.9) 0.302
Female, N (%) 52 (40) 7 (30.4) 45 (42.1)
Season Winter, N (%) 29 (22.3) 6 (26.1) 23 (21.5) 0.864
Spring, N (%) 68 (52.3) 11 (47.8) 57 (53.3)
Summer, N (%) 33 (25.4) 6 (26.1) 27 (25.2)

Rotavirus RNA detection

For detecting Rotavirus, the samples were evaluated using VP6-specific primers reported previously by WHO (Table 1)(18). PCR was performed in a 45 μl total reaction volume containing 4.5 μl of 10X PCR buffer, 2μl of 50mM MgCl2, 1 μl of 10mM dNTP, 5 µL of cDNA, 0.2 µL of TaqDNA polymerase 5U, 1 µl of primers for the VP6 gene (20pmol/μl), and 35.3μl of RNase-free H2O.

Table 1.

Used primers and PCR conditions in this study

Primers Sequences (53) Target PCR conditions Amplicon size (bp)
Forward Reverse Denaturation Annealing Extension
Universal GACGGVGCRACTACATGGT GTCCAATTCATNCCTGGTG VP6 94°C/60s 55°C/60s 72°C/60s 380
G typing ATGTATGGTATTGAATATACCAC AACTTGCCACCATTTTTTCC VP7 94°C/60s 52°C/60s 72°C/60s 881
CAAGTACTCAAATCAATGATGG G1 94°C/60s 42°C/120s 72°C/60s 620
CAATGATATTAACACATTTTCTGTG G2 522
ACGAACTCAACACGAGARG G3 682
CGTTTCTGGTGAGGAGTTG G4 452
GTCACACCATTTGTAAATTCG G8 754
CTTGATGTGACTAYAAATAC G9 177
CCGATGGACGTAACGTTGTA G12 266
P typing TATGCTCCAGTNAATTGG ATTGCATTTCTTTCCATAATG VP4 94°C/60s 50°C/60s 72°C/60s 663
CTATTGTTAGAGGTTAGAGTC P4 94°C/60s 45°C/120s 72°C/60s 362
TGTTGATTAGTTGGATTCAA P6 146
TCTACTTGGATAACGTGC P8 224

Determination of G-P combinations

The G-typing was done according to the WHO protocol for all positive cases from the previous step (18). The PCR was carried out using the consensus primers of the VP7 gene. Briefly, 5 µL of amplified fragments was used as a template for the second round by the primer combinations of VP7-R as well as G1, G2, G3, G4, G8, G9, and G12-F. The Nested-PCR reaction mixture was prepared in a 47µl volume containing 4.8 µl of 10X buffer, 2.5 µl of 50mM MgCl2, 1 µl of 10mM (each) dNTP, 0.2 µl of Taq polymerase 5U, 1 µl of each primer (20 pmol/µl), and 30.5 µl of nuclease-free H2O(18). The first-round of the P-typing was performed using a pair of specific primers of the gene coding for RotavirusVP4 protein. In a second-round PCR for P-typing and G typing is carried out under the same conditions (18).

Statistical analysis

The age of patients was expressed as the mean±SD. The student’s t and chi-square tests were used to determine significance of means for quantitative and qualitative variables, respectively. P-value < 0.05 was considered statistically significant. SPSS statistics software version 22 (IBM, NY, USA) was employed for all statistical analyses.

Results

Our study was performed within one year, where 130 stool samples were obtained from up to 15-year-old children with acute infectious gastroenteritis. The mean age of the patients was 32.09 months (standard deviation, ±32.68 months). Also, 60% and 40% of the patients were males and females, respectively. The results of the PCR showed that from a total of 130 patients, 22 cases (16.9%) were positive for VP6 by RT-PCR. Among them, males generally suffered more than females (15/7). The highest prevalence of Rotavirus was observed in the spring season (10/22, 45.5%). There were no significant correlations between age, gender, season, and the Rotavirus infection.

The clinical symptoms in 22 Rotavirus-positive patients included vomiting (n=15 cases, 68.2%), fever (n=13 cases, 59.1%), and abdominal pain (n=8 cases, 36.4%). The results showed no significant difference in these symptoms between Rotavirus-positive and Rotavirus-negative patients (P > 0.05). There were no significant differences in WBC and RBC counts of stool and C-reactive protein (CRP) as well as erythrocyte sedimentation rate (ESR) of blood between the patients. G and P typing was done for 22 samples. Among different genotypes, G1 was mostly the predominant serotype (27%), accounting for 22% of all VP7-positive isolates, followed by G9 (18%), G2 (9%), G3 (9%), G4 (9%), G12 (5%). None of the strains revealed the presence of G8 genotypes (0%) and 5 samples (23%) were non-typable.

As for VP4 genotyping (P type), the frequency of P type was P8 (50%), P6 (23%), P4 (14%), and 13% were P-non-typable respectively (Fig 1).

Figure 1.

Figure 1

RT-PCR typing of group A Rotavirus strains. Lanes: M, DNA marker ladder; 1,4,6(P4); 2,8(P6); 7(P8) of VP4 genotype

The dominant G-P combination was G1P [8] (32%), followed by G2P [4] (11%), G9P [6] (11%), and G3P [8] (11%). Further, G4P [6], G4P [8], G9P [4], G9P [8], and G12P [6] were detected in 25% of all evaluated specimens. In 10% of cases, no combination was observed.

Discussion

Rotaviruses are the single most important cause of severe diarrhea in infants and young children worldwide with the average RVA positive value in Iran reported as 40.04% (15). The management of RVA circulating strains and the introduction of the RVA vaccine have a high priority for the healthcare system. Thus, it is critical to identify Iranian RVA strains and also to investigate the potential antigenic disparities between Iranian circulating and vaccine strains before introducing vaccines (19, 20).

In the present study, using the RT-PCR method according to the WHO method, we were able to identify 22 cases of Rotavirus among 130 children (17%) under the age of 15 years with acute infectious gastroenteritis. The mean prevalence of Rotavirus was 78% in Shahr-e Kord and 79.2% in Tehran (21). Also, the prevalence of rotavirus reported by Moghim in Isfahan (2012) and Hassanzadeh in Shiraz (2001) was 12.6% and 11.3%, respectively (22, 23). Our findings are similar with a previous study conducted by Modares et al. who determined the prevalence of Rotavirus as 19% (24). Similar to results reported from different parts of Iran and other countries, diarrhea was the most common symptom observed in association with Rotavirus infection, followed by vomiting and fever. Our study also identified that Rotavirus infections were significantly higher in the spring season (10/22, 45.5%), which is in agreement with epidemiological studies in other regions of the world (25). According to gender data, the prevalence rate of disease was higher in boys than in girls (60%) which is in line with the findings of De Wit et al. study (26).

Overall, G1, G2, G3, G4, and G9 were the five most common predominant genotypes worldwide. The current study revealed that the G1 type was mostly the predominant serotype (27%), followed by G9 (18%), G4 (9%), G3 (9%), G2 (9%), and G12 (5%) types which had a lower frequency. Numerous molecular epidemiological studies have shown that G1 is the most common circulating. Azaran et al., from southwest Iran showed that G1 and G2 are the most prevalent rotavirus genotypes (27). Farahtaj et al. determined that G1 was the most common type (28). Based on reports, the G2 has also been found to be common worldwide and the its prevalence has changed over time (29). These findings were different from the Khalili et al. reports on 200 subjects out of whom a prevalence 13% was found for G2 (30). In another study by Eesteghamati et al., the G2 genotype was reported in 5.5% of their cases (31). Unlike Kargar et al. report where G4 was dominant (32), our data showed that 9% of Rotavirus gastroenteritis were caused by this genotype. The prevalence of the G3 genotype was 24.6% reported by Motamedi‐Rad et al. (2017) (33), while our results showed a prevalence of 9 %among our patients. Furthermore, in this analysis, one G12 type was identified. In recent years, the spread of G12 seems to have accelerated further, particularly in combination with either P[8] or P[6] (34). Unlike the results found in Sierra Leone, Turkey, Morocco, and China (35-38), G8 genotype was not detected in the present study. In recent years, the increasing importance of the G9 type in many countries including Latin America, Brazil, and Iran has demonstrated(39). Due to the variable vaccine response and infectivity rate of the G9 type, this genotype has recently gained sufficient epidemiological concern worldwide. However, with the emergence of G9 and G12 Rotavirus genotypes, expectedly we have a number of gastroenteritis cases due to low heterotypic protection (15, 40). Different investigations in developing and industrialized countries have demonstrated a necessity for new generations of rotavirus vaccines to include G9 strains (39, 41). The P genotyping analysis also showed that the isolated Rotavirus strains with the P8 made up 50% of the cases, followed by P6 and P4 types with rates of 23% and 14%, respectively. Mousavi-Nasab et al. showed (2019) that P8 as the dominant genotype for VP4 gene (42). The results of P and G combination in this study revealed that G1 [8] genotype was dominant with the prevalence of 32%, followed by G2 [4] (11%), G9 [6] (11%),and G3 [8] (11%). G4 [6], G4 [8], G9 [4], G9 [8], and G12 [6].

Our result is in agreement with previous studies by Lorestani et al. who showed G1P8 as dominant genotype with a prevalence rate of 57.8% (43). In our study, 13.7% of detected RV was non-typable, and that was similar to a previous study by Kargar et al., who reported it as 12.5% in Jahrom, south Iran (32).

In summary, this is the first report of determining rotavirus strains in Qom city of Iran. Nevertheless, large-scale study and continuous surveillance appear to be necessary. Such studies assist in rotavirus vaccine introduction by policy makers and designing new effective vaccines.

Acknowledgment

We thank the Technology and Research Council of Qom University of Medical Sciences for supporting the study.

Conflict of interests

The authors declare that they have no conflict of interest.

References

  • 1.Akoua-Koffi C, Kouadio VA, Atteby JJY. Hospital-based surveillance of rotavirus gastroenteritis among children under 5 years of age in the Republic of Ivory Coast: a cross-sectional study. BMJ Open. 2014;4:e003269. doi: 10.1136/bmjopen-2013-003269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Desselberger U. Rotaviruses. Virus Res. 2014;190:75–96. doi: 10.1016/j.virusres.2014.06.016. [DOI] [PubMed] [Google Scholar]
  • 3.Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, et al. Rotavirus infection. Nat Rev Dis Primers. 2017;3:1–16. doi: 10.1038/nrdp.2017.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mukherjee A, Chawla-Sarkar M. Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies. Indian J Virol. 2011;22:11–23. doi: 10.1007/s13337-011-0039-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect. 2003;9:247–62. doi: 10.1046/j.1469-0691.2003.00560.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Goudarzi M, Goudarzi H, Alebouyeh M, Azimi Rad M, Shayegan Mehr FS, Zali MR, et al. Antimicrobial susceptibility of clostridium difficile clinical isolates in iran. Iran Red Crescent Med J. 2013;15:704–11. doi: 10.5812/ircmj.5189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ozsari T, Bora G, Kaya B, Yakut K. The prevalence of rotavirus and adenovirus in the childhood gastroenteritis. Jundishapur J Microbiol. 2016;9:22–26. doi: 10.5812/jjm.34867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pesavento J, Crawford S, Estes M, Prasad BV. Rotavirus proteins: structure and assembly. Reoviruses: Entry, Assembly and Morphogenesis: Springer. 2006:189–219. doi: 10.1007/3-540-30773-7_7. [DOI] [PubMed] [Google Scholar]
  • 9.Nasab SDM, Sabahi F, Makvandi M, Samiee SM, Nadji SA, Ravanshad M. Epidemiology of rotavirus-norovirus co-infection and determination of norovirus genogrouping among children with acute gastroenteritis in Tehran, Iran. Iran Biomed J. 2016;20:280–6. doi: 10.22045/ibj.2016.05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hu L, Crawford SE, Hyser JM, Estes MK, Prasad BV. Rotavirus non-structural proteins: structure and function. Curr Opin Virol. 2012;2:380–8. doi: 10.1016/j.coviro.2012.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nirwati H, Wibawa T, Aman AT, Soenarto Y. Genotyping of rotavirus by using RT-PCR methods. Indones J Biotechnol. 2013;18:8–13. [Google Scholar]
  • 12.Burnett E, Parashar U, Tate J. Rotavirus vaccines: Effectiveness, safety, and future directions. Paediatr Drugs . 2018:1–11. doi: 10.1007/s40272-018-0283-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Troeger C, Blacker BF, Khalil IA, Rao PC, Cao SJ, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1211–28. doi: 10.1016/S1473-3099(18)30362-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Troeger C, Khalil IA, Rao PC, Cao SJ, Blacker BF, Ahmed T, et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. Jama Pediatrics. 2018;172:958–65. doi: 10.1001/jamapediatrics.2018.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jalilvand S, Roohvand F, Arashkia A, Shoja Z. Update on epidemiology and circulating genotypes of rotavirus in Iranian children with severe diarrhea: 1986-2015. Int J Travel Med Glob Health. 2018;6:7–10. [Google Scholar]
  • 16.Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215:1666–72. doi: 10.1093/infdis/jix186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sindhu KNC, Babji S, Ganesan SK. Impact of rotavirus vaccines in low and middle-income countries. Curr Opin Infect Dis. 2017;30:473–81. doi: 10.1097/QCO.0000000000000397. [DOI] [PubMed] [Google Scholar]
  • 18.Organization WH. Manual of rotavirus detection and characterization methods. 2009. [Google Scholar]
  • 19.Monavari SHR, Hadifar S, Mostafaei S, Miri A, Keshavarz M, Babaei F, et al. Epidemiology of rotavirus in the Iranian children: A systematic review and meta-analysis. J Glob Infect Dis. 2017;9:66. doi: 10.4103/0974-777X.205173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine. 2006;24:2718–31. doi: 10.1016/j.vaccine.2005.12.048. [DOI] [PubMed] [Google Scholar]
  • 21.Moradi-Lakeh M, Shakerian S, Yaghoubi M, Esteghamati A, Shokraneh F, Baradaran HR, et al. Rotavirus infection in children with acute gastroenteritis in Iran: a systematic review and meta-analysis. Int J Prev Med. 2014;5:1213. [PMC free article] [PubMed] [Google Scholar]
  • 22.Moghim S, Manesh SA, Hosseini NS, Azadani HN. Frequency of Rotavirus in children under three years of age with gastroenteritis in ALZAHRA hospital. J Res Med Sci. 2012;30:11–15. [Google Scholar]
  • 23.Hassanzadeh P, Al-e-Yasin F. The prevalence of bacterial and viral agents in fecal specimens of children in Shiraz. J Kerman University Med Sci. 2001;8:11–16. [Google Scholar]
  • 24.Modaress S, Rahbarimanesh AA, Edalat R, Sohrabi A, Motamedirad M, Modarres S, et al. Human rotavirus genotypes detection among hospitalized children, a study in Tehran, Iran. Arch Iran Med. 2011;14:39. [PubMed] [Google Scholar]
  • 25.Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali M, Sanaei M, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis. 2009:200. doi: 10.1086/605050. [DOI] [PubMed] [Google Scholar]
  • 26.De Wit M, Koopmans M, Van der Blij J, Van Duynhoven Y. Hospital admissions for rotavirus infection in the Netherlands. Clin Infect Dis. 2000;31:698–704. doi: 10.1086/314025. [DOI] [PubMed] [Google Scholar]
  • 27.Azaran A, Makvandi M, Samarbafzadeh A, Neisi N, Hoseinzadeh M, Rasti M, et al. Study on Rotavirus infection and Its genotyping in children below 5 years in south west Iran. Iran J Pediatr. 2016;26:e2080. doi: 10.5812/ijp.2080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Farahtaj F, Gallimore CI, Iturriza-Gomara M, Taremi M, Zali M, Edalatkhah H, et al. Rotavirus VP7, VP4 and VP6 genotypes co-circulating in Tehran, Iran, between 2003 and 2004. Epidemiol Infect. 2007;135:834–8. doi: 10.1017/S0950268806007485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Intamaso U, Poomipak W, Chutoam P, Chotchuang P, Sunkkham W, Srisopha S. Genotype distribution and phylogenetic analysis of rotaviruses in Thailand and emergence of uncommon genotypes. Arch Clin Microbiol. 2017;8:60–70. [Google Scholar]
  • 30.Khalili B, Cuevas L, Reisi N, Dove W, Cunliffe N, Hart CA. Epidemiology of rotavirus diarrhoea in Iranian children. J Med Virol. 2004;73:309–12. doi: 10.1002/jmv.20092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali M, Sanaei M, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis. 2009;200:S244–S7. doi: 10.1086/605050. [DOI] [PubMed] [Google Scholar]
  • 32.Kargar M, Zare M, Najafi A. Molecular epidemiology of rotavirus strains circulating among children with gastroenteritis in Iran. Iran J Pediatr. 2012;22:63. [PMC free article] [PubMed] [Google Scholar]
  • 33.Motamedi‐Rad M, Farahmand M, Arashkia A, Jalilvand S, Shoja Z. VP7 and VP4 genotypes of rotaviruses cocirculating in Iran, 2015 to 2017: Comparison with cogent sequences of Rotarix and RotaTeq vaccine strains before their use for universal mass vaccination. J Med Virol. 2020;92:1110–23. doi: 10.1002/jmv.25642. [DOI] [PubMed] [Google Scholar]
  • 34.Kheyami AM, Nakagomi T, Nakagomi O, Dove W, Hart CA, Cunliffe NA. Molecular epidemiology of rotavirus diarrhea among children in Saudi Arabia: first detection of G9 and G12 strains. J Clin Microbiol. 2008;46:1185–91. doi: 10.1128/JCM.02244-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jere K, Sawyerr T, Seheri L, Peenze I, Page N, Geyer A, et al. A first report on the characterization of rotavirus strains in Sierra Leone. J Med Virol. 2011;83:540–50. doi: 10.1002/jmv.21999. [DOI] [PubMed] [Google Scholar]
  • 36.Wang YH, Kobayashi N, Zhou X, Nagashima S, Zhu ZR, Peng JS, et al. Phylogenetic analysis of rotaviruses with predominant G3 and emerging G9 genotypes from adults and children in Wuhan, China. J Med Virol. 2009;81:382–9. doi: 10.1002/jmv.21387. [DOI] [PubMed] [Google Scholar]
  • 37.Meral M, Bozdayı G, Ozkan S, Dalgıç B, Alp G, Ahmed K. Rotavirus prevalence in children with acute gastroenteritis and the distribution of serotypes and electropherotypes. Mikrobiyol Bul. 2011;45:104–12. [PubMed] [Google Scholar]
  • 38.Benhafid M, Youbi M, Klena JD, Gentsch JR, Teleb N, Widdowson MA, et al. Epidemiology of rotavirus gastroenteritis among children< 5 years of age in Morocco during 1 year of sentinel hospital surveillance, June 2006–May 2007. J Infect Dis. 2009;200:S70–S5. doi: 10.1086/605048. [DOI] [PubMed] [Google Scholar]
  • 39.Linhares A, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis. 2006;43:312–4. doi: 10.1086/505493. [DOI] [PubMed] [Google Scholar]
  • 40.Banyai K, Bogdan A, Kisfali P, Molnar P, Mihaly I, Melegh B, et al. Emergence of serotype G12 rotaviruses, Hungary. Emerg Infect Dis. 2007;13:916–9. doi: 10.3201/eid1306.061181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Velázquez RF, Linhares AC, Muñoz S, Seron P, Lorca P, DeAntonio R, et al. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr. 2017;17:14. doi: 10.1186/s12887-016-0771-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Mousavi-Nasab SD, Sabahi F, Kaghazian H, Paryan M, Mirab-Samiee S, Ghaderi M, et al. A Real-Time RT-PCR assay for genotyping of Rotavirus. Iran Biomed J. 2020;24:399–404. doi: 10.29252/ibj.24.6.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lorestani N, Moradi A, Teimoori A, Masodi M, Khanizadeh S, Hassanpour M, et al. Molecular and serologic characterization of rotavirus from children with acute gastroenteritis in northern Iran, Gorgan. BMC Gastroenterol. 2019;19:100. doi: 10.1186/s12876-019-1025-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gastroenterology and Hepatology From Bed to Bench are provided here courtesy of Shahid Beheshti University of Medical Sciences

RESOURCES